BioInvent International
LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV)
"The powerful combination of BioInvent's R&D and in-house manufacturing provides invaluable support to our clinical development and facilitates the execution of our current clinical portfolio. The integration of functions, on top of world leading science, makes it possible for us to develop novel treatments for patients suffering from serious diseases. The solid balance sheet and strong, loyal shareholders support us in achieving our goals," said Martin Welschof, BioInvent CEO.
Events in the quarter
• (R) BioInvent announced a second clinical trial collaboration and supply agreement with Merck to evaluate BI-1808 in combination with Keytruda® (pembrolizumab) in patients with advanced solid tumors.
• Emma Meurling joined Bioinvent as Human Resource (HR) Director.
Events after the period
• BioInvent and Transgene announced that preclinical data for BT-001, a novel oncolytic virus delivering an anti-CTLA-4 antibody for the treatment of solid tumors, will be presented at SITC in November 2021.
• New data on the lead drug candidate BI-1206 Phase 1/2a study in non-Hodgkin's lymphoma (NHL) to be presented at the ASH (American Society of Hematology) conference December 11-14.
• New production agreement with CRUK to produce additional batch of anti-HER3 antibody.
• Prof. Eggermont new member of the BioInvent Scientific Advisory Board.
Financial information
Third quarter 2021
• Net sales SEK 3.0 (16.3) million.
• Loss after tax SEK -62.6 (-32.9) million.
• Loss after tax per share before and after dilution SEK -1.07 (-1.00).
• Cash flow from operating activities -57.5 (-31.4) million.
January - September 2021
• Net sales SEK 14.5 (48.6) million.
• Loss after tax SEK -199.7 (-104.9) million.
• Loss after tax per share before and after dilution SEK -3.79 (-4.00).
• Cash flow from operating activities SEK -170.1 (-91.8) million.
• Liquid funds and long-term investments as of September 30, 2021: SEK 1,445.3 (642.1) million.
The complete report is attached as pdf and is available on the company's website www.bioinvent.com/investors/#financialreports.
(R)= Regulatory event
Contacts
Cecilia Hofvander
Senior Director Investor Relations
Tel: +46 46 286 85 50
Email. cecilia.hofvander@bioinvent.com
About Us
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The Company's validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company's own clinical development pipeline or for additional licensing and partnering.
The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com. Follow us on Twitter: @BioInvent.
Attachments
SOURCE: BioInvent International
View source version on accesswire.com:
https://www.accesswire.com/670065/BioInvent-International-AB-Interim-Report-January--September-2021
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Air T, Inc. Announces Closing of Regional Express Acquisition18.12.2025 23:10:00 CET | Press release
MINNEAPOLIS, MN / ACCESS Newswire / December 18, 2025 / Air T, Inc. (NASDAQ:AIRT) is pleased to announce the successful closing of its acquisition of Regional Express Holdings Limited (Rex), Australia's leading regional airline. Air T now owns 100% of Rex and looks forward to beginning a new chapter for Rex and the regional communities it serves across Australia. The transaction includes a comprehensive financing structure designed to support Rex's operations and future growth: Air T is providing a $50 million AUD credit facility that is funded by one of our investor partners. We anticipate that Rex will use this facility to bring its fleet fully back into service, from approximately 31 flyers currently to 45 flyers within the next two years. The Commonwealth of Australia will continue to be a secured creditor of Rex. Rex will have access to an additional undrawn $60 million AUD loan from the Commonwealth of Australia to support the overhaul of its current fleet of Saab 340s and genera
Ascension Advisory Completes Industrial Sale Leaseback in Toledo, Spain on Behalf of OpenGate Capital17.12.2025 23:05:00 CET | Press release
TOLEDO, SPAIN / ACCESS Newswire / December 17, 2025 / Ascension Advisory is pleased to announce the successful closing of an industrial sale leaseback transaction in Toledo, Spain, completed on behalf of Aluminium Solutions Group (ASG), a portfolio company of OpenGate Capital. Aluminium Solutions Group is an industrial manufacturing business specializing in aluminium extrusion and value-added aluminium solutions, serving a range of industrial and commercial end markets across Europe. OpenGate Capital is a global private equity firm specializing in the acquisition and operation of businesses to create new value through operational improvements, innovation and growth. The transaction involved a 44,026 square meter industrial facility situated on a 56,330 square meter site, representing a mission-critical manufacturing asset for ASG's operations in Spain, Extrusiones de Toledo ("EXTOL"). As part of the sale leaseback, EXTOL executed a new long-term triple-net lease, allowing the company t
TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care17.12.2025 18:45:00 CET | Press release
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / December 17, 2025 / TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, and the National Association of Pediatric Nurse Practitioners (NAPNAP), The Leader in Pediatric Education for Nurse Practitioners®, have announced they will jointly develop a global micro-credential to help advance the knowledge and skills of the world's pediatric nursing workforce. The collaboration aims to improve health outcomes for infants, children, adolescents, and young adults worldwide amid a global shortage of pediatric nurses that is limiting access to evidence-based pediatric care in countries of all income levels. The partners envision that their micro-credential program will be the centerpiece of a larger initiative to engage global stakeholders in educating, assessing, and credentialing the nursing workforce in this specialization. A micro-credential is a short, competency-based recognition for specific s
SK tes Achieves NCSC CAS-S Accreditation for Comprehensive Onsite and Offsite Data Destruction and Sanitisation Services Across the UK17.12.2025 15:00:00 CET | Press release
LONDON, UK / ACCESS Newswire / December 17, 2025 / SK tes, a global leader in secure technology lifecycle management, is proud to announce that both its UK sites - Cannock, West Midlands and Irvine, Scotland - have achieved accreditation to the Sanitisation Assurance (CAS-S) Scheme by the UK's National Cyber Security Centre (NCSC) for its secure on-site shredding service. This dual-site accreditation enables SK tes to deliver secure data destruction and sanitisation services nationwide from these two strategic locations, to support clients across the whole of the UK. The CAS-S scheme certifies commercial IT asset sanitisation providers to rigorous government standards, ensuring central government (HMG) customers can easily access services that fully comply with NCSC requirements. With this accreditation, SK tes is authorised to provide: Mobile (offsite) destruction services up to SECRET: Devices are destroyed at the client's premises, ensuring sensitive information never leaves the org
AWM Wraps Up 2025 with Multiple Surf Venue Grand Openings16.12.2025 16:05:00 CET | Press release
Ending the Year on a High Note SOLANA BEACH, CA / ACCESS Newswire / December 16, 2025 / American Wave Machines, the surf technology company behind PerfectSwell® Surf Venues worldwide, concludes banner year with two grand openings and expansion into new markets. São Paulo Surf Club Key Year End Highlights: Riyue Bay: November 11 China Tourism Group celebrated the grand opening of PerfectSwell® Riyue Bay Surf Resort Zion: November 20 The Foundation Ceremony of PerfectSwell® Zion took place in Utah. São Paulo: November 29 JHSF celebrated the grand opening of São Paulo Surf Club "This year's results reflect a herculean effort from the team on improving efficiency, product delivery and commissioning. Finishing with two grand openings in one month is perhaps our most notable achievement. With PerfectSwell® Zion well underway and a third pool starting up in Brazil, 2026 will be just as memorable." - CEO Bruce McFarland "The wave quality achievements made this year have exceeded the expectatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom